Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis

Leukemia Research

Volumn 38, Issue 4, 2014, Pages 509-515

  Baptista, Maria Joao ^a,c   Calpe, Eva ^a   Fernandez, Eva ^b   Colomo, Lluis ^b   Cardesa Salzmann, Teresa Marta ^b   Abrisqueta, Pau ^a   Bosch, Francesc ^a   Crespo, Marta ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

BL; Glycosylation; IGHV; Intraclonal diversity; SHM; Superantigens

Indexed keywords

CARBOHYDRATE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN 3; IMMUNOGLOBULIN HEAVY CHAIN 4 34; STAPHYLOCOCCUS PROTEIN A; SUPERANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CARCINOGENESIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; HUMAN CELL; IGHV GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; REGULATORY MECHANISM;

BL; GLYCOSYLATION; IGHV; INTRACLONAL DIVERSITY; SHM; SUPERANTIGENS;

ADOLESCENT; ADULT; AGED; BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MALE; MIDDLE AGED; SUPERANTIGENS;

EID: 84897110727     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.01.001     Document Type: Article

References (30)

1. Swerdlow S.H., Campo E., Harris L.N., Jaffe E.S., Pileri S.A., Stein H., et al. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, IARC press, Lyon.
2. Stamatopoulos K., Belessi C., Moreno C., Boudjograh M., Guida G., Smilevska T., et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007, 109:259-270.
3. Zibellini S., Capello D., Forconi F., Marcatili P., Rossi D., Rattotti S., et al. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 2010, 95:1792-1796.
4. Bomben R., Dal-Bo M., Benedetti D., Capello D., Forconi F., Marconi D., et al. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. Clin Cancer Res 2010, 16:620-628.
5. Stevenson F., Sahota S., Zhu D., Ottensmeier C., Chapman C., Oscier D., et al. Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev 1998, 162:247-259.
6. Zhu D., McCarthy H., Ottensmeier C.H., Johnson P., Hamblin T.J., Stevenson F.K. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 2002, 99:2562-2568.
7. Zhu D., Ottensmeier C.H., Du M.-Q., McCarthy H., Stevenson F.K. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br J Haematol 2003, 120:217-222.
8. Murray F., Darzentas N., Hadzidimitriou A., Tobin G., Boudjogra M., Scielzo C., et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008, 111:1524-1533.
9. Chapman C.J., Mockridge C.I., Rowe M., Rickinson A.B., Stevenson F.K. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 1995, 85:2176-2181.
10. Riboldi P., Ikematsu W., Brambilla B., Caprani C., Gerosa M., Casali P. Diversity and somatic hypermutation of the Ig VHDJH, V kappa J kappa, and V lambda J lambda gene segments in lymphoma B cells: relevance to the origin of the neoplastic B cell clone. Hum Immunol 2003, 64:69-81.
11. Klein U., Klein G., Ehlin-Henriksson B., Rajewsky K., Küppers R. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med 1995, 1:495-505.
12. Chapman C.J., Zhou J.X., Gregory C., Rickinson A.B., Stevenson F.K. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 1996, 88:3562-3568.
13. Isobe K., Tamaru J.-I., Nakamura S., Harigaya K., Mikata A., Ito H. VH gene analysis in sporadic Burkitt's lymphoma: somatic mutation and intraclonal diversity with special reference to the tumor cells involving germinal center. Leuk Lymphoma 2002, 43:159-164.
14. Riboldi P., Gaidano G., Schettino E.W., Steger T.G., Knowles D.M., Dalla-Favera R., et al. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 1994, 83:2952-2961.
15. Eclache V., Magnac C., Pritsch O., Delecluse H.J., Davi F., Raphaël M., et al. Complete nucleotide sequence of Ig V genes in three cases of Burkitt lymphoma associated with AIDS. Leuk Lymphoma 1996, 20:281-290.
16. Ikematsu H., Cerutti A., Zan H., Knowles D.M., Ikematsu W., Casali P. Ongoing hypermutation in the Ig V(D)J gene segments and c-myc proto-oncogene of an AIDS lymphoma segregates with neoplastic B cells at different sites: implications for clonal evolution. Hum Immunol 2000, 61:1242-1253.
17. Lefranc M.-P., Giudicelli V., Ginestoux C., Jabado-Michaloud J., Folch G., Bellahcene F., et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2009, 37:D1006-D1012.
18. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
19. Graille M., Stura E.A., Corper A.L., Sutton B.J., Taussig M.J., Charbonnier J.B., et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000, 97:5399-5404.
20. Potter K.N., Hobby P., Klijn S., Stevenson F.K., Sutton B.J. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol 2002, 169:3777-3782.
21. Brezinschek H.P., Foster S.J., Brezinschek R.I., Dörner T., Domiati-Saad R., Lipsky P.E. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest 1997, 99:2488-2501.
22. Crespo M., Bosch F., Villamor N., Bellosillo B., Colomer D., Rozman M., et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003, 348:1764-1775.
23. Coelho V., Krysov S., Ghaemmaghami A.M., Emara M., Potter K.N., Johnson P., et al. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci USA 2010, 107:18587-18592.
24. Chapman C.J., Wright D., Stevenson F.K. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis. Leuk Lymphoma 1998, 30:257-267.
25. Capello D., Martini M., Gloghini A., Cerri M., Rasi S., Deambrogi C., et al. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica 2008, 93:1178-1185.
26. Sebastián E., Alcoceba M., Balanzategui A., Marín L., Montes-Moreno S., Flores T., et al. Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype. Am J Pathol 2012, 181:1879-1888.
27. McCann K.J., Ashton-Key M., Smith K., Stevenson F.K., Ottensmeier C.H. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 2009, 113:4677-4680.
28. Pugh-Bernard A.E., Silverman G.J., Cappione A.J., Villano M.E., Ryan D.H., Insel R.A., et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001, 108:1061-1070.
29. Kostareli E., Hadzidimitriou A., Stavroyianni N., Darzentas N., Athanasiadou A., Gounari M., et al. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Leukemia 2009, 23:919-924.
30. Bellan C., Lazzi S., Hummel M., Palummo N., de Santi M., Amato T., et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005, 106:1031-1036.